Selumetinib Sulfate
The sulfate salt of selumetinib, an orally active, small molecule with potential antineoplastic activity. Selumetinib is an ATP-independent inhibitor of mitogen-activated protein kinase kinase (MEK or MAPK/ERK kinase) 1 and 2. MEK 1 and 2 are dual specificity kinases that are essential mediators in the activation of the RAS/RAF/MEK/ERK pathway, are often upregulated in various cancer cells, and are drivers of diverse cellular responses, including proliferation. Inhibition of both MEK1 and 2 by selumetinib prevents the activation of MEK1/2 dependent effector proteins and transcription factors, thereby leading to an inhibition of cellular proliferation in various cancers. [ ]
Term info
Selumetinib Sulfate
- 1H-Benzimidazole-6-Carboxamide, 5-((4-Bromo-2-Chlorophenyl)Amino)-4-Fluoro-N-(2- Hydroxyethoxy)-1-Methyl-, Sulfate (1:1)
- 1h-Benzimidazole-6-Carboxamide,5-((4-Bromo-2-Chlorophenyl)Amino)-4-Fluoro-N-(2- Hydroxyethoxy)-1-Methyl-, Sulphate (1:1)
- 5-((4-Bromo-2-Chlorophenyl)amino)-4-Fluoro-N-(2-Hydroxyethoxy)-1-Methyl-1H- Benzimidazole-6-Carboxamide Sulfate
- 5-((4-Bromo-2-Chlorophenyl)amino)-4-Fluoro-N-(2-Hydroxyethoxy)-1-Methyl-1H- Benzimidazole-6-Carboxamide Sulphate
- AZD-6244 Hydrogen Sulfate
- AZD6244 Hydrogen Sulfate
- AZD6244 Hydrogen Sulphate
- SELUMETINIB SULFATE
- Selumetinib Sulfate
- Selumetinib Sulphate
NCIT_C116978, NCIT_C128784, NCIT_C63923, NCIT_C157711, NCIT_C116977, NCIT_C157712
943332-08-9
C17H15BrClFN4O3.H2O4S
CTRP, FDA
Selumetinib Sulfate
807ME4B7IJ
http://purl.obolibrary.org/obo/NCIT_C66939
http://purl.obolibrary.org/obo/NCIT_C26486
792495
792495
Selumetinib Sulfate
Pharmacologic Substance
C2987007
C95225
Term relations
- Antineoplastic Enzyme Inhibitor
- Mitogen-Activated Protein Kinase Kinase Inhibitor
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Enzyme Inhibition
- Chemical_Or_Drug_Has_Physiologic_Effect some Inhibition of Cell Proliferation
- Chemical_Or_Drug_Affects_Gene_Product some Mitogen-Activated Protein Kinase Kinase Kinase 1